Form:Supplied as a liquid in PBS, 0.09% sodium azide.
Specificity:Recognizes a human melanoma-specific antigen present in melanocytic cells and junctional nevi. Does not cross-react with normal melanocytes, intradermal nevus cells or other neoplasms including sarcomas, carcinomas and glial tumors.